Sanjay Shrivastava Acquires 5,400 Shares of enVVeno Medical Corporation (NASDAQ:NVNO) Stock

enVVeno Medical Corporation (NASDAQ:NVNO) Director Sanjay Shrivastava acquired 5,400 shares of the business’s stock in a transaction on Tuesday, December 24th. The shares were purchased at an average price of $2.90 per share, with a total value of $15,660.00. Following the transaction, the director now owns 9,288 shares in the company, valued at $26,935.20. The trade was a 138.89 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

enVVeno Medical Price Performance

NASDAQ:NVNO traded up $0.24 during trading hours on Thursday, reaching $3.06. 429,034 shares of the company traded hands, compared to its average volume of 113,650. enVVeno Medical Corporation has a 1-year low of $2.45 and a 1-year high of $6.97. The stock has a market cap of $53.66 million, a P/E ratio of -2.37 and a beta of 1.22. The firm’s 50-day moving average is $3.19 and its 200-day moving average is $4.31.

enVVeno Medical (NASDAQ:NVNO) last issued its quarterly earnings data on Thursday, October 31st. The company reported ($0.35) EPS for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.02). As a group, research analysts predict that enVVeno Medical Corporation will post -1.3 earnings per share for the current year.

Institutional Trading of enVVeno Medical

A number of hedge funds have recently made changes to their positions in the stock. Geode Capital Management LLC grew its position in enVVeno Medical by 7.8% in the third quarter. Geode Capital Management LLC now owns 150,676 shares of the company’s stock worth $506,000 after acquiring an additional 10,902 shares in the last quarter. Corsair Capital Management L.P. acquired a new stake in enVVeno Medical in the 3rd quarter valued at approximately $390,000. Westside Investment Management Inc. grew its stake in shares of enVVeno Medical by 128.0% in the third quarter. Westside Investment Management Inc. now owns 88,375 shares of the company’s stock worth $297,000 after acquiring an additional 49,613 shares during the last quarter. Maven Securities LTD acquired a new position in enVVeno Medical during the 3rd quarter valued at $295,000. Finally, Hohimer Wealth Management LLC bought a new position in shares of enVVeno Medical during the 3rd quarter worth about $286,000. 34.71% of the stock is owned by hedge funds and other institutional investors.

About enVVeno Medical

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).